Literature DB >> 10991667

Glial cells and Parkinson's disease.

E C Hirsch1.   

Abstract

Parkinson's disease is a neurodegenerative disease characterised by a massive loss of dopaminergic neurons in the substantia nigra. Yet glial cells may also participate in the pathophysiology of the disease. Indeed, glial cells can produce trophic factors which may stimulate neuronal survival or, alternatively, they could produce toxic compounds which may be involved in neuronal degeneration. This paper reviews the potentially protective or deleterious effects of glial cells in the substantia nigra of patients with Parkinson's disease.

Entities:  

Mesh:

Year:  2000        PMID: 10991667     DOI: 10.1007/pl00007762

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  10 in total

1.  Early and late gene changes in MPTP mice model of Parkinson's disease employing cDNA microarray.

Authors:  Silvia Mandel; Edna Grünblatt; Gila Maor; Moussa B H Youdim
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

2.  Impact of endogenous nitric oxide on microglial cell energy metabolism and labile iron pool.

Authors:  Benoît Chénais; Hamid Morjani; Jean-Claude Drapier
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

Review 3.  New insights on Parkinson's disease genes: the link between mitochondria impairment and neuroinflammation.

Authors:  Dorit Trudler; Yuval Nash; Dan Frenkel
Journal:  J Neural Transm (Vienna)       Date:  2015-04-17       Impact factor: 3.575

Review 4.  Mechanisms of islet amyloidosis toxicity in type 2 diabetes.

Authors:  Andisheh Abedini; Ann Marie Schmidt
Journal:  FEBS Lett       Date:  2013-01-18       Impact factor: 4.124

5.  Isolation of cortical microglia with preserved immunophenotype and functionality from murine neonates.

Authors:  Stefano G Daniele; Amanda A Edwards; Kathleen A Maguire-Zeiss
Journal:  J Vis Exp       Date:  2014-01-30       Impact factor: 1.355

6.  PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice.

Authors:  M B Watson; H Nobuta; C Abad; S K Lee; N Bala; C Zhu; F Richter; M-F Chesselet; J A Waschek
Journal:  Neuroscience       Date:  2013-03-14       Impact factor: 3.590

Review 7.  Role of prostaglandins in neuroinflammatory and neurodegenerative diseases.

Authors:  Isabel Vieira de Assis Lima; Leandro Francisco Silva Bastos; Marcelo Limborço-Filho; Bernd L Fiebich; Antonio Carlos Pinheiro de Oliveira
Journal:  Mediators Inflamm       Date:  2012-06-18       Impact factor: 4.711

8.  Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade.

Authors:  W Michael Zawada; Gregg P Banninger; Jennifer Thornton; Beth Marriott; David Cantu; Angela L Rachubinski; Mita Das; W Sue T Griffin; Susan M Jones
Journal:  J Neuroinflammation       Date:  2011-10-05       Impact factor: 8.322

9.  Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease.

Authors:  Emma Thornton; Robert Vink
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

10.  Anti-Inflammatory Effect of Triterpene Saponins Isolated from Blue Cohosh (Caulophyllum thalictroides).

Authors:  Yeonju Lee; Jae-Chul Jung; Zulfiqar Ali; Ikhlas A Khan; Seikwan Oh
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-05       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.